NDT Advance Access published online on July 26, 2005
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfi016
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 University of Iowa Hospitals, Iowa City, USA
* To whom correspondence should be addressed.
Editorial Comment
Melagatran anticoagulation during haemodialysis--Primum non nocere
Michael J. Flanigan, E-mail: michael-flanigan{at}uiowa.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P.-O. Attman Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1738 - 1738. [Full Text] [PDF] |
||||
